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1. Definitions
Atopy. Atopy is a personal and/or familial tendency, usually 
in childhood or adolescence, to become sensitised and produce 
IgE antibodies in response to ordinary exposure to allergens, 
usually proteins. As a consequence, such individuals can 
develop the  typical symptoms of asthma, rhinoconjunctivitis 
or eczema.1
Allergy. Allergy is a hypersensitivity reaction initiated by 
immunological mechanisms. Allergy can be antibody- or 
cell-mediated. In the majority of cases the antibody typically 
responsible for an allergic reaction belongs to the IgE isotype, 
and these individuals may be referred to as suffering from an 
IgE-mediated allergy.1
Atopic individuals must have clinical symptoms. Some 30 - 
40% of individuals in developed countries are allergic, but only 
a proportion of these have atopic diseases, which include 
asthma (5 - 10%), rhinitis (10 - 20%) and food allergy (1 - 3%). 
In population studies allergic diseases peak at different ages. 
Food allergy and atopic eczema are predominant in early 
childhood, whereas asthma shows a biphasic peak and rhinitis 
peaks in the second or third decade. 
Atopic diseases manifest as hyper-responsiveness in the 
target organ, whether skin, nose, lung or gastrointestinal 
tract. This hyper-responsiveness (allergy) may have both IgE-
mediated and non-IgE-mediated components. The situation 
is further complicated because allergen exposure in allergic 
subjects may increase target organ hyper-responsiveness, 
which results in exaggerated symptoms on exposure to 
nonspecific irritants (tobacco smoke, changes in temperature, 
etc.) in allergic subjects. Only a proportion of atopic subjects 
develop disease, and atopic individuals may have casual 
factors in their disease independent of their atopic status. 
Furthermore, increased nonspecific responsiveness lowers the 
threshold for symptoms on subsequent allergen exposure.
2. Diagnostic approach 
Allergy diagnosis depends primarily on the clinical history. The 
history, aided by a physical examination, guides objective tests 
of IgE sensitivity. Either skin tests or allergen-specific serum 
IgE measurements (RAST) are used to focus on the following 
questions:
•   Is the patient allergic?
•   Does allergy contribute to the patient’s symptoms?
•   What are the clinically relevant allergens?
There should be a high index of suspicion of allergy in 
patients presenting with symptoms of asthma, rhinitis or 
eczema, particularly if there is an associated personal or family 
history of other atopic disease. On the basis of a positive 
initial history, a limited number of skin-prick tests (SPTs) and 
possibly specific IgE measurements (radio-allergosorbent tests 
– RASTs) to commonly prevailing aero-allergens (Table I) or 
foods should be performed to confirm or exclude atopy. Few 
foods commonly provoke allergic reactions; they include cow’s 
milk, egg and peanut in infants and young children, and fish, 
shellfish, peanuts, tree nuts, fruit and spices in older children 
and adults. Physical examination may determine which 
organ or organs is or are involved. When both the clinical 
history and results of SPTs (or specific IgE) are negative, one 
can exclude allergy with a high degree of confidence and no 
specific treatment for allergy is indicated. A positive history 
and positive tests help in rationalising treatment, initiating 
specific allergen avoidance measures and selecting appropriate 
immunotherapy.
2.1 Skin-prick testing
SPTs with allergen extracts are the favoured method of in 
vivo testing for IgE-mediated sensitivity. Testing for a limited 
number of common allergens (Table I) may confirm or exclude 
atopy. The quality of extracts is important for reliable results. 
Standardised extracts are currently available for most common 
inhalant allergens and for some food allergens. Many patients 
with documented food allergy fail to react to commercial 
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Table I. Prevailing aero-allergens in South Africa18 
All regions House-dust mites (Der p 1 and Der f 1)
  Rye and Bermuda grass
  Aspergillus, Alternaria, Cladosporium
  Cat and dog
Western Cape Add:  Oak and plane tree pollen,
            Blomia tropicalis
            Epicoccium fungal spore
            Cockroach
Gauteng  Add:  Tree pollens including cypress
Farming areas Add:  Zea mays pollen
            Horse
            Blomia tropicalis
Health care  Add:  Latex
worker
Grain industry Add:  Storage mites, wheat and rye
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extracts but react to fresh extracts of the food,2,3  e.g. fruits,3 
celery,4 shellfish and fish.5,6  Interpretation of SPTs may also be 
difficult in children younger than 2 years because of reduced 
reactivity to histamine in this age group.7  Results of SPTs 
must always be expressed in a quantitative manner that can 
be interpreted by other practitioners. SPTs must be performed 
in a setting where personnel and equipment are available 
for resuscitation (because of a very low but definite risk of 
anaphylaxis8).
2.2 Blood tests (in vitro)
Total IgE was initially used as a diagnostic marker of 
allergic disease, but it has limitations: IgE is elevated in 
allergic diseases and in non-allergic conditions, e.g. parasitic 
infestation, and half of IgE-mediated allergic patients have a 
total IgE within the normal range.9 The predictive value of this 
test is therefore rather limited in allergy diagnosis.
Specific IgE (RAST) measures allergen-specific IgE to 
allergens in patient serum. In the case of inhalant allergens a 
level of >0.35 kU/l is considered positive (sensitivity 60 - 80%, 
specificity 90%);  for food allergy, the cut-off values for positive 
(indicating clinical reactivity) appear to be much higher (Fig. 1).10 
The respective advantages of SPTs and specific IgE are shown 
in Table II. 
2.3 Multi-allergen IgE antibody screening assays
These are useful when a patient provides an equivocal history 
for allergic disease (making it difficult to pinpoint with 
reasonable certainty the appropriate allergens to test for). The 
multi-allergen screen for aero-allergens is the Phadiatop12 
(Phadia, Uppsala) and for foods the Fx5 (Phadia, Uppsala). 
Phadiatop is usually reported as positive or negative. A positive 
test indicates that the patient may be sensitive to one or more 
of the following inhalants: house-dust mites, grass, mould, cat, dog. 
The laboratory should then contact the doctor to discuss testing 
for the relevant allergen(s). The Fx5E is a quantitative test; a 
level of >0.35 kU/l is considered positive and indicates that the 
patient may be sensitive to one or more of the following foods: 
cow’s milk, egg white, fish, wheat, peanut, soya. The laboratory 
should contact the referring doctor to discuss further testing. A 
negative multi-allergen screen reduces the probability that IgE-
mediated allergic disease is the cause of the patient’s clinical 
problems.
2.4 Mast cell tryptase 
The serum level of β-tryptase can be useful as a marker of 
mast cell activation in the definitive diagnosis of anaphylaxis.13 
Tryptase levels peak at 45 - 60 minutes and may remain 
elevated for several hours (up to 24 hours).14 Ideally, three serial 
measurements should be performed: the first soon after the 
reaction, the second a few hours later, and a baseline level 24 
hours later.
2.5 CAST testing
Some patients may develop symptoms due to sensitivity 
to various food additives (colourants, flavourants or 
preservatives) or medications, which are not IgE mediated. 
These chemical sensitivities may be confirmed by CAST testing 
(cellular antigen stimulation test) and should be discussed with 
a specialist.
An algorithmic approach to testing for inhalant and food 
sensitivities is outlined in Figs 1 and 2.
2.6 Unproven diagnostic tests 
There are many allergy ‘diagnostic’ tests performed by 
ecologists and alternative practitioners. These tests are of 
unproven value, are often time-consuming and expensive, and 
are not to be recommended (Table III).15-17
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Table II. SPT compared with specific IgE
SPT    Specific IgE
• Inexpensive  • Not affected by concurrent
      drugs, e.g. antihistamines
• Immediate results  • Not influenced by skin disease
• Educational value  • Completely safe
• Generally more sensitive • Tests for wider range of possible
       allergens
Table III. Diagnostic tests of unproven value
• Neutralisation provocation (Miller) tests (based on multiple skin tests; environmental allergens include smoke, petrol, tobacco, etc.)
• Leukocytotoxic tests
• Hair analysis
•  Vega testing (a ‘black box’ electrical test). The test is based on the addition of food extracts to a chamber contained within an electrical 
circuit completed by the patient
• Applied kinesiology (based on muscle weakness)
• Auricular cardiac reflex testing (based on pulse rate)
• ALCAT
• IgG measurements
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History is consistent
with food allergy
History is unclear (e.g.
symptoms delayed)
History is negative, but screening
is required (e.g. because of family
history)
History is negative (e.g. child eats
the food regularly and has no
related symptoms)
Perform skin-prick test and Fx5E/CAP-
food-specific IgE measurements (RAST)
Do not perform test – child does
not have food allergy
>95% PPV for test results <95% PPV for test results
Diagnose food allergy
Post-test probability
>95%
Diagnosis of food allergies with the use of 95% PPV for specific
IgE and skin-prick tests
Food 95% PPV for 95% PPV for
specific IgE10 skin-prick test
wheal
diameter11
(kU/l) (mm)
______________________________________________________
Egg 6 7
Milk 32 8
Peanuts 15 8
Fish 20 7
Tree nuts 15 8
Use test results with
likelihood ratio
Diagnose food allergy
Consider supervised
food challenge
Post-test probability
<95%
Obtain history
Fig. 1. Diagnostic algorithm for food allergy (adapted from Lack19). This treatment algorithm can be used for any food allergy if the test result is associated 
with a positive predictive value (PPV) of >95% and if the likelihood ratio is known for a given test result. A double-blind, placebo- 
controlled food challenge should not be performed if the patient has a history of severe anaphylaxis. In the skin-prick test, the mean wheal diameter obtained 
depends in part on the age of the patient, the extract used, the method of performing the test, and the site on the body where the test is performed. Values for 
specific types of tree nuts have not been validated.
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SKIN-PRICK
TEST
Specific
IgE
(RAST)
CONFIRMS
INHALANT
ALLERGY
IF INDIVIDUAL
ALLERGEN(S) NOT
SUSPECTED
IF INDIVIDUAL
ALLERGEN(S)
SUSPECTED
PHADIATOP
INHALANT SCREEN
SPECIFIC IgE
INDIVIDUAL
ALLERGENS
[Please delete this box!]
Negative
*Positive
**Positive
**Positive
TREATMENT including
avoidance measures
and immunotherapy (if
indicated)
*Wheal size >3 mm diameter.
**Specific IgE >0.35 kU/l.
INHALANT
ALLERGY
UNLIKELY
Negative
Negative
Fig. 2. Diagnostic algorithm for inhalant allergy.
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